These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6789153)

  • 1. [Concentrations of fosfomycin in serum and lung tissue].
    Adam D; Ritscher R
    MMW Munch Med Wochenschr; 1981 May; 123(21):893-5. PubMed ID: 6789153
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum and lung tissue levels of fosfomycin in humans.
    Faragó E; Kiss IJ; Nábrádi Z
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):554-8. PubMed ID: 7228451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diffusion of fosfomycin into bone tissue in man].
    Sirot J; Lopitaux R; Dumont C; Rampon S; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):522-4. PubMed ID: 6348661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target site penetration of fosfomycin in critically ill patients.
    Joukhadar C; Klein N; Dittrich P; Zeitlinger M; Geppert A; Skhirtladze K; Frossard M; Heinz G; Müller M
    J Antimicrob Chemother; 2003 May; 51(5):1247-52. PubMed ID: 12668580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colorimetric determination of fosfomycin in biological fluids].
    Csiba A
    Acta Pharm Hung; 1980 Jan; 50(1):12-20. PubMed ID: 7361552
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-pharmacological examination of patients treated with carbenicillin following thoracic surgery (carbenicillin level in lung tissue)].
    Kiss J; Iván E; Biró L; Faragó E; Arr M; Fábián E
    Orv Hetil; 1972 Oct; 113(42):2527-33. PubMed ID: 5073465
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of subinhibiting concentrations of fosfomycin on the ultrastructure of E. coli K 126].
    Carlone NA; Cattaneo O; Cuffini AM; Ferrero M
    G Batteriol Virol Immunol; 1980; 73(7-12):260-71. PubMed ID: 7030849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentration of antibiotics in various jaw tissues. Concentration of fosfomycin (X)].
    Pignanelli M; Badile S; Salvato A; Scaglione F; Fraschini F
    Dent Cadmos; 1984 Oct; 52(10):127-30. PubMed ID: 6399265
    [No Abstract]   [Full Text] [Related]  

  • 9. Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.
    Pullukcu H; Tasbakan M; Sipahi OR; Yamazhan T; Aydemir S; Ulusoy S
    Int J Antimicrob Agents; 2007 Jan; 29(1):62-5. PubMed ID: 17189097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal insufficiency and fosfomycin.
    Gobernado M; García J; Santos M; Panadero J; Diosdado N
    Chemotherapy; 1977; 23 Suppl 1():200-3. PubMed ID: 832516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous and intramuscular pharmacokinetics of a single-daily dose of disodium-fosfomycin in cattle, administered for 3 days.
    Sumano LH; Ocampo CL; Gutierrez OL
    J Vet Pharmacol Ther; 2007 Feb; 30(1):49-54. PubMed ID: 17217401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosfomycin and rifampin disk diffusion tests for detection of Escherichia coli mutator strains.
    Galán JC; Tato M; Baquero MR; Turrientes C; Baquero F; Martinez JL
    J Clin Microbiol; 2004 Sep; 42(9):4310-2. PubMed ID: 15365030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and selective liquid chromatographic/tandem mass spectrometric method for the determination of fosfomycin in human plasma.
    Li L; Chen X; Dai X; Chen H; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):171-7. PubMed ID: 17574936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.
    Schintler MV; Traunmüller F; Metzler J; Kreuzwirt G; Spendel S; Mauric O; Popovic M; Scharnagl E; Joukhadar C
    J Antimicrob Chemother; 2009 Sep; 64(3):574-8. PubMed ID: 19578081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
    Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
    J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects].
    Di Nola F; Soranzo ML
    Minerva Med; 1983 Feb; 74(6):239-48. PubMed ID: 6828256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
    Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
    J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
    Aykut Arca E; Karabiber N
    Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.